Use of and microbial resistance to antibiotics in China: a path to reducing antimicrobial resistance

Journal of International Medical Research

Volumn 45, Issue 6, 2017, Pages 1768-1778

  Cui, Dan ^a   Liu, Xinliang ^a   Hawkey, Peter ^b   Li, Hao ^a   Wang, Quan ^a   Mao, Zongfu ^a   Sun, Jing ^c  

^a WUHAN UNIVERSITY   (China)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Antimicrobial resistance; appropriate use; containment

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; PRESCRIPTION DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CHINA; CONFERENCE PAPER; DRUG USE; EDUCATION; GOVERNMENT REGULATION; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PRACTITIONER; HOSPITAL; HUMAN; MEDICAL INFORMATION; NONHUMAN; PATIENT; PRESCRIPTION; DRUG EFFECT;

ANTI-BACTERIAL AGENTS; CHINA; DRUG RESISTANCE, BACTERIAL; HUMANS; PRESCRIPTION DRUGS;

EID: 85038568759     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060516686230     Document Type: Conference Paper

References (50)

1. The World Health Organization. Antimicrobial resistance: global report on surveillance 2014. http://www.who.int/drugresistance/documents/surveillancereport/en/ (accessed 21 November 2016)
2. Zhang R, Eggleston K, Rotimi V, Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Global Health 2006; 2: 6–6.
3. Sun HL, Wang H, Chen MJ, Antimicrobial resistant surveillance of gram-positve cocci isolated from 12 teaching hospitals in China in 2009. Zhonghua Nei Ke Za Zhi 2010; 49: 735–740. [in Chinese, English Abstract].
4. Xu X, Zhang P, Fan X, Mohnarin 2008 report: results of Staphylococcus and enterococcus resistance. Chin J Antibiot 2010; 35: 536–543. http://www.cnki.com.cn/Article/CJFDTotal-ZKSS201007013.htm (accessed 16 January 2017). [in Chinese, English Abstract].
5. Liu W, Chen L, Li H, Novel CTX-M {beta}-lactamase genotype distribution and spread into multiple species of Enterobacteriaceae in Changsha, Southern China. J Antimicrob Chemother 2009; 63: 895–900.
6. CHINET Annual Report 2014. http://www.clinphar.cn/thread-325066-1-1.html (accessed 21 November 2016)
7. Xiao Y, Giske CG, Wei ZQ, Epidemiology and characteristics of antimicrobial resistance in China. Drug Resist Updat 2011; 14: 236–250.
8. Wen X, Ren N, Wu A, Antimicrobiai resistance of bacteria and changing trend in China Nosocomial Infection Surveillance System. Chin Infect Control 2009; 8: 389–396,408.
9. China National Health Development Research Center. China national health accounts report. Beijing, CNHDRC; 2015
10. National Bureau of Statistics of China. China statistical yearbook, Beijing: China Statistics Press, 2015.
11. The World Health Organization. The world medicines situation 2011-expenditures, Geneva: WHO, 2011.
12. Center for Health Statistics and Information, MoH, P.R.China. Research on health service of primary health care facilities in China, Beijing: China Medical Union University Publishing House, 2008.
13. Holloway KA et al. Progress in Standard Indicators of Medicines Use Over 20 Years. Abstract 337 of the 3rd International Conference of International Use of Medicines. 2011. http://www.inrud.org/ICIUM/ConferenceMaterials/default_015.html (accessed 8 November 2015)
14. The World Health Organization. World health statistics 2011, Geneva: WHO, 2011.
15. Xiao Y, Report of public security concerns of irrational use of antibiotics, Beijing: Chinese Science and Technology Association, 2007.
16. Tang J, Minutes of the national seminar on promoting rational use of medicines. National Medical Journal of China 1985; 65: 258–263. http://zhyxzz.yiigle.com/CN112137198505/850875.htm (accessed 16 January 2017). [in Chinese].
17. Yang YH, Fu SG, Peng H, Abuse of antibiotics in China and its potential interference in determining the etiology of pediatric bacterial diseases. Pediatr Infect Dis J 1993; 12: 986–988.
18. Center for Health Statistics and Information, MoH, P.R.China. Research on Health Service of Primary Health Care Facilities in China, Beijing: China Medical Union University Publishing House, 2008.
19. WHO-China 2008-9 project report on improving prophylaxis antibiotics for clean surgery. WP/2008/CHN, PE: 04.07
20. Sun J, Shen X, Li M, Changes of patterns in antibiotic use in Chinese public hospitals (2005–2012) and a benchmark comparison with Sweden in 2012. J Glob Antimicrob Resist 2015; 3: 95–102.
21. State Food and Drug Administration, P.R.China. The announcement of strengthening the supervision of antimicrobials distribution in the retail pharmacies. Document No. 289 of 2003. http://www.sfda.gov.cn/WS01/CL0844/10126.html (accessed 21 November 2016)
22. Ministry of Health, P.R.China. Clinical guidelines for antimicrobials clinical use. Document 285 of 2004
23. Ministry of Health, P.R.China. Announcement of setting up the monitoring network for antimicrobials clinical use and resistance. 2005. http://www.nhfpc.gov.cn/zhuzhan/zcjd/201304/b0da0ebfc7b3428f98d435a29cfa4250.shtml (accessed 21 November 2016)
24. Ministry of Health, P.R.China. Prescription Administration. Document No. 53 of 2006. http://www.nhfpc.gov.cn/mohyzs/s3572/200804/29279.shtml (accessed 21 November 2016)
25. Ministry of Health, P.R.China. Pharmacy administration in health facilities. Document No. 11 of 2011. http://www.nhfpc.gov.cn/yzygj/s3593/201103/4119b5de252d45ac916d420e0d30fda7.shtml (accessed 21 November 2016)
26. Ministry of Health, P.R.China. Announcement of strengthening monitoring of medicines use. Document No. 13 of 2009. http://govinfo.nlc.gov.cn/gtfz/zfgb/wsb/20095070/201010/t20101011_446876.html# (accessed 21 November 2016)
27. Ministry of Health, P.R.China. Regulation on antimicrobials clinical use. Ministerial Order No. 84 of 2012. http://www.nhfpc.gov.cn/zhuzhan/wsbmgzl/201205/347e8d20a6d442ddab626312378311b4.shtml (accessed 21 November 2016)
28. National Health and Family Planning Commission. National Action Plan to Contain Antimicrobial Resistance (2016–2020). http://www.nhfpc.gov.cn/yzygj/s3593/201608/f1ed26a0c8774e1c8fc89dd481ec84d7.shtml (accessed 21 November 2016)
29. China Food and Drug Administration. ADR monitoring annual report 2015. http://www.sda.gov.cn/WS01/CL0051/60952.html (accessed 21 November 2016)
30. Ministry of Health, P.R.China. China Health Statistics Yearbook 2013. http://www.nhfpc.gov.cn/htmlfiles/zwgkzt/ptjnj/year2013/index2013.html (accessed 1 July 2016)
31. Van Boeckel TP, Gandra S, Ashok A, Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis 2014; 14: 742–750.
32. The World Health Organization. Global health observatory data repository. World health statistics, WHO: Geneva, 2014.
33. Health system reform office of the State Council. Three year summary report of deepening the health system reform. Unpublished report, Beijing: National Development and Reform Commission, 2012.
34. Sun J. Systematic review of interventions on antibiotic prophylaxis in surgery in Chinese hospitals during 2000–2012. J Evid Based Med 2013; 6: 126–135.
35. The World Bank. Fixing the Public Hospital System in China. China Health Policy Notes No.2, Washington DC: The World Bank, 2010.
36. The World Health Organization. Pharmaceutical Policy in China: Issues and Problems Report prepared for the Chinese government for the national health system reform. WHO Archives. http://archives.who.int/tbs/ChinesePharmaceuticalPolicy/English_Background_Documents/summarypapers/PPChinaIssuesProblemsShenglan.doc (accessed 21 November 2016)
37. Yip WC, Hsiao W, Meng Q, Realignment of incentives for health-care providers in China. Lancet 2010; 375: 1120–1130.
38. Sun J. International updates for improving use of medicines. China Pharmacy 2012; 23: 1249–1252. http://mall.cnki.net/magazine/Article/ZGYA201214003.htm (accessed 16 January 2017). [in Chinese, English Abstract].
39. World Health Assembly Resolutions 51.17. Emerging and other communicable diseases: antimicrobial resistance. 1998; 58.27, Improving the containment of antimicrobial resistance. 2005; 60.16, Progress in the rational use of medicines, including better medicines for children. Geneva: WHO, 2007
40. Holloway KA. Combating in-appropriate use of medicines. Expert Rev Clin Pharmacol 2011; 4: 335–348.
41. le Grand A, Hogerzeil HV, Haaijer-Ruskamp FM. Intervention research in rational use of drugs: a review. Health Policy Plann 1999; 14: 89–102.
42. Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev 2005, pp. CD003539–CD003539.
43. Sketris IS, Langille Ingram EM, Lummis HL. Strategic opportunities for effective optimal prescribing and medication management. Can J Clin Pharmacol 2009; 16: e103–e125.
44. Baker R, Camosso-Stefinovic J, Gillies C, Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2010, pp. CD005470–CD005470.
45. World Health Organization. WHO Medicines Use in Primary Care in Developing and Transitional Countries. http://apps.who.int/medicinedocs/documents/s16073e/s16073e.pdf (accessed 21 November 2016)
46. Yip W, Hsiao W. Harnessing the privatization of China’s fragmented health-care delivery. Lancet 2014; 384: 805–818.
47. Mills A. Health care systems in low- and middle-income countries. N Engl J Med 2014; 370: 552–557.
48. World Health Organization. WHO policy perspectives on medicines — promoting rational use of medicines: core components, Geneva: WHO, 2002.
49. Moreno-Serra R. The impact of cost-containment policies on health expenditure: Evidence from recent OECD experiences. OECD Journal on Budgeting 2014; 13: 1–29.
50. Dusheiko M, Gravelle H, Jacobs R, The effect of financial incentives on gatekeeping doctors. evidence from a natural experiment. J Health Econ 2006; 25: 449–478.